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Abstract: Identifying the toxicity of nanoparticles (NPs) is an important area of research as 
the number of nanomaterial-based consumer and industrial products continually rises. In addi-
tion, the potential inflammatory effects resulting from pulmonary NP exposure are emerging as 
an important aspect of nanotoxicity. In this study, the toxicity and inflammatory state resulting 
from tungsten carbide–cobalt (WC–Co) NP exposure in macrophages and a coculture (CC) 
of lung epithelial cells (BEAS-2B) and macrophages (THP-1) at a 3:1 ratio were examined. 
It was found that the toxicity of nano-WC–Co was cell dependent; significantly less toxicity was 
observed in THP-1 cells compared to BEAS-2B cells. It was demonstrated that nano-WC–Co 
caused reduced toxicity in the CC model compared to lung epithelial cell monoculture, which 
suggested that macrophages may play a protective role against nano-WC–Co-mediated toxicity in 
CCs. Nano-WC–Co exposure in macrophages resulted in increased levels of interleukin (IL)-1β 
and IL-12 secretion and decreased levels of tumor necrosis factor alpha (TNFα). In addition, 
the polarizing effects of nano-WC–Co exposure toward the M1 (pro-inflammatory) and M2 
(anti-inflammatory) macrophage phenotypes were investigated. The results of this study indi-
cated that nano-WC–Co exposure stimulated the M1 phenotype, marked by high expression of 
CD40 M1 macrophage surface markers.
Keywords: nanoparticle, nanotoxicity, inflammation, macrophage, lung disease
Introduction
The majority of nanomaterial or nanoparticle (NP) exposure occurs via the pulmonary 
route1,2 and, upon inhalation, macrophages are recruited to the area as a part of the 
body’s defense mechanism to promote particle clearance from the lungs.3,4 Phagocytic 
by nature, macrophages quickly identify and engulf the NPs as a part of their inherent 
physiological response mechanism.4,5 However, during this process, the macrophage 
accumulates a large quantity of NPs. Depending on the NPs, this accumulation within 
the cell may cause toxicity or induce a secondary immune response and stimulate 
a local or systemic inflammatory process.5–7 Therefore, along with addressing the 
direct toxic effects of the multitude of NPs currently used in consumer products, it is 
important to consider the inflammatory response that these materials may generate 
upon exposure.5
Macrophage-mediated inflammation typically occurs in response to bacterial or 
viral infections and tissue injuries as a part of the normal healing process, but it can 
also occur as a result of foreign particle inhalation.5,8 Depending on the stimulus, 
macrophages differentiate into either a “classically” activated M1 or an “alternatively” 
activated M2 phenotype, which have signature characteristics that distinguish them 
from one another.9–14 Classical M1 macrophages play important roles in infection 
clearance, typically in response to lipopolysaccharide (LPS), which stimulates a 
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high-level secretion of pro-inflammatory cytokines such 
as tumor necrosis factor alpha (TNFα) and interleukin (IL) 
12p70 (IL-12) and promotes a type 1 T helper (Th1) immune 
response.9–11,14 Macrophages activated by other factors, such 
as endogenous IL-4 and glucocorticoid hormones, fall under 
the alternatively activated M2 phenotype. M2 macrophages 
generally secrete high levels of IL-10 and IL-1β to promote 
the type 2 T helper (Th2) immune response.9–11,14 In addition, 
emerging evidence indicates that macrophage activation/
polarization toward the M1 or M2 phenotype may play critical 
roles in tumor growth and cancer progression.8,9,15,16 It is 
believed that M1 macrophages promote tumor resistance due 
to their high-level secretion of pro-inflammatory cytokines 
and potent effector cell functions.10,11 In contrast, M2 mac-
rophages are believed to possess tumor-promoting functions 
due to their promotion of angiogenesis, tissue remodeling and 
repair mechanisms.10,11 Further, the tumor microenvironment 
can influence tumor-associated macrophages to undergo a 
“phenotypic switching” from M1 to M2, and thus tumor-
promoting, phenotype.10,15
Given this body of literature, it has been suggested that 
inflammation resulting from pulmonary NP exposure may 
play a role in the toxicity associated with exposure,5–7,17–21 and 
that the inflammatory state resulting from particle exposure 
may play a role in cancer progression.5,8 This is especially 
concerning in occupational settings,22,23 where workers 
undergo pulmonary exposure to NPs on a daily basis.17,24 
In particular, exposure to tungsten carbide–cobalt (WC–Co) 
NPs in occupational settings is known to cause hard metal 
lung disease (HMLD), characterized by progressive inflam-
mation and fibrosis of the lung,25–29 which is further associ-
ated with a twofold increased risk of lung cancer.30–32 While 
the toxicity of WC–Co particles has been studied,33–50 the 
relationship between WC–Co toxicity, inflammation and 
lung cancer remains poorly understood.
In addition, there is limited information regarding the 
interaction of multiple cell types during WC–Co NP expo-
sure (ie, immune cells and epithelial cells), as the majority of 
previous in vitro studies employed single-cell (monoculture) 
models in their examination of WC–Co toxicity.33,34,36,40–42,45,47,48 
This design is a disadvantage, as coculture (CC) models more 
closely represent the in vivo environment during a WC–Co 
NP exposure. To address this gap in understanding, the cur-
rent study examined the effects of nano-WC–Co particle 
exposure in vitro using monoculture and CC cell models 
composed of macrophages (THP-1) and lung epithelial cells 
(BEAS-2B) to assess the toxicity, stimulation of inflamma-
tory cytokine secretion and M1/M2 macrophage polarization. 
We hypothesized that exposure to nano-WC–Co stimulates 
inflammation in macrophages and may promote polarization 
toward the M1 pro-inflammatory macrophage phenotype.
Materials and methods
Materials and reagents
THP-1 human monocyte cell line (TIB-202) and BEAS-2B 
cells were purchased from American Type Culture Collection 
(ATCC, Manassas, VA, USA). Nano-WC–Co composite 
particles were purchased from Inframat Advanced Materials 
(Manchester, CT, USA). RPMI-1640 medium for THP-1 cell 
culture was purchased from ATCC. Phosphate-buffered saline 
(PBS), Dulbecco’s Modified Eagle’s Medium (DMEM), 
0.25% trypsin/ethylenediaminetetraacetic acid (EDTA), 
versene (EDTA-based cell detachment reagent), penicillin/
streptomycin, beta-mercaptoethanol and fetal bovine serum 
(FBS) were purchased from Lonza (Allendale, NJ, USA). 
Isopropanol, hydrochloric acid, Triton-X-100, thiazolyl blue 
tetrazolium bromide (MTT reagent), phorbol-12-mystirate-
13-acetate (PMA), LPS and enzyme-linked immunosorbent 
assay (ELISA) kits for human IL-12 (#RAB0252), IL-10 
(#RAB0244), IL-1β (#RAB0273) and TNFα (#RAB0476) 
were purchased from Sigma-Aldrich (St Louis, MO, USA). 
Flow cytometry staining buffer (containing 0.2% bovine 
serum albumin and sodium azide), recombinant human IL-4, 
human immunoglobulin G (IgG), antihuman CD40-APC and 
antihuman CD206-FITC antibodies were purchased from BD 
Biosciences (Franklin Lakes, NJ, USA).
Nano-Wc–co particle preparation
Nano-WC–Co stock particle suspensions (5 mg/mL) were 
prepared in sterile PBS (containing 10% FBS to prevent 
agglomeration) by sonication under 120 W power output, 
frequency 20 kHz, for 1 min with an Omni International Sonic 
Ruptor (Omni International, Kennesaw, GA, USA). Sonica-
tion was performed in 30 mL plastic vials immobilized in an 
ice bath to prevent heating during particle dispersion. Dilute 
nano-WC–Co particle suspensions (1–1,000 μg/mL) were 
prepared on the day of each experiment in DMEM containing 
10% FBS from the 5 mg/mL stock particle suspension.
Cell culture and THP-1 macrophage (M0) 
activation
BEAS-2B cells were maintained and passaged upon con-
fluence in DMEM supplemented with 10% FBS and 1% 
penicillin/streptomycin. THP-1 cells were maintained and 
passaged upon confluence in RPMI-1640 supplemented 
with 10% FBS, 1% penicillin/streptomycin and 0.5 mM 
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beta-mercaptoethanol. All cells were maintained in an incu-
bator at 37°C and 5% CO
2
. Differentiation of THP-1 cells 
to macrophages (M0) was achieved through the addition of 
10 ng/mL PMA. After 48 h, THP-1 to M0 differentiation was 
confirmed via examination of cell morphology using a light 
microscope,13,51 where M0 cells underwent a signature change 
in morphology and became adherent to the culture dish. For 
CC, M0 cells were rinsed once with PBS and incubated with 
versene (EDTA-based cell dissociation reagent) for 15 min. 
M0 cells were then pipetted gently to ensure detachment from 
the culture dish and resuspended in DMEM at the desired 
concentration for CC seeding.
Macrophage and epithelial cell CC
To establish the CC at a ratio of 3:1 (lung epithelial cell: 
macrophage), BEAS-2B cells were trypsinized, resuspended 
in DMEM and seeded in a 96-well plate at a density of 
1.5×105 cells/mL and allowed to adhere for 1 h. BEAS-2B 
attachment was confirmed using light microscopy prior to the 
addition of M0 cells. M0 cells were seeded directly on top 
of the BEAS-2B monolayer at a density of 5×104 cells/mL 
in DMEM and cocultured for 24 h to allow attachment and 
cellular interaction prior to nano-WC–Co exposure.
Nano-Wc–co particle exposure
Nano-WC–Co particle exposure was achieved by aspirating 
the medium from each well and replacing immediately with 
an equivalent volume of nano-WC–Co particle suspension at 
a concentration of 1, 10, 100 or 1,000 μg/mL and incubated 
at 37°C and 5% CO
2 
for exposure periods of 2, 6, 12, 24 and 
48 h; controls were treated with LPS (100 ng/mL) or IL-4 
(20 ng/mL). For the M1/M2 flow cytometry experiments, 
M0 cells were treated with either control LPS, IL-4 or 0, 1, 
10 and 100 μg/mL nano-WC–Co for exposure periods of 
1, 2 and 5 days.
Cell viability after nano-WC–Co 
exposure
Following nano-WC–Co exposure, the medium containing 
nano-WC–Co was aspirated from each well and cells were 
rinsed once with PBS to remove excess particles. Then, 
100 μL un-supplemented DMEM was added to each well, 
followed by the addition of 10 μL MTT reagent to achieve 
a final concentration of 0.5 mg/mL MTT per well. Cells 
were incubated for 2 h at 37°C and 5% CO
2
 to allow con-
version of the soluble tetrazolium salt (yellow) to formazan 
crystals (purple). Crystal formation was confirmed using 
light microscopy. Next, 100 μL of solubilization solution 
(0.1 M HCl in isopropanol containing 10% Triton-X) was 
added to each well to dissolve the formazan crystals, and 
the absorbance of each well was recorded immediately at 
570 nm using a Bio-Tek μQuant microplate reader (Bio-
Tek, Winooski, VT, USA). Blank values were subtracted 
from all absorbance readings. Cell viability was calculated 
by dividing the absorbance of nano-WC–Co-treated cells by 
the absorbance of control cells receiving media treatment 
only and converted to a percentage. The presence of WC–Co 
particles did not interfere with the MTT assays in our studies 
as we described earlier.49
Macrophage polarization assay
THP-1 cells were seeded at a density of 5×105 cells/mL in 
RPMI-1640 containing 10 ng/mL PMA in a 12-well culture 
dish and incubated for 48 h to stimulate M0 cell differentia-
tion. Media were then aspirated from each well and replaced 
with DMEM containing 100 ng/mL LPS (M1 stimulus/
positive control), 20 ng/mL IL-4 (M2 stimulus/positive 
control) and 0, 1, 10 or 100 μg/mL nano-WC–Co particles. 
M0 cells were incubated with the M1, M2 or nano-WC–Co 
stimulus for 1, 2 and 5 days at 37°C and 5% CO
2
.
Flow cytometry
Following M1/M2/WC–Co exposure, M0 cells were rinsed 
once with PBS, detached with versene (described earlier) 
and transferred to 15 mL polystyrene tubes. Cells were cen-
trifuged at 1,200 rpm for 7 min to pellet and resuspended 
in 1 mL ice-cold flow cytometry staining buffer. M0 cells 
were counted on a hemocytometer and a total of 3×105 cells 
per sample were transferred to 5 mL polystyrene tubes for 
subsequent staining. After centrifugation, cell pellets were 
resuspended in 100 μL staining buffer containing 10 μg 
human IgG and incubated for 30 min over ice to block mac-
rophage Fc receptors and minimize nonspecific antibody 
binding. Next, cells were rinsed with 1 mL cold staining 
buffer to remove excess IgG and resuspended in 80 μL buffer. 
Then, 10 μL of each antibody (anti-CD40-APC or anti-
CD206-FITC) was added to each appropriate tube, including 
positive/negative and single-stain controls and incubated for 
1 h over ice. After staining, cells were rinsed three times with 
1 mL cold staining buffer to remove unbound antibodies. 
After the final rinse, cell pellets were resuspended in 100 μL 
0.4% paraformaldehyde to fix and stored overnight at 4°C. 
The next day, fixed cells were centrifuged, resuspended in 
300 μL staining buffer and analyzed immediately on a BD 
LSR Fortessa flow cytometer. Instrument settings were 
defined at the beginning of each experiment using the cells 
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only (no stain) and single-stain controls (CD40-APC only 
and CD206-FITC only) and applied for all subsequent experi-
mental samples. Representative flow cytometry dot plots of 
macrophage staining controls are shown in Figure S1.
Inflammatory cytokine secretion in 
response to nano-Wc–co exposure
The concentrations of IL-12, IL-10, IL-1β and TNFα in cell 
culture supernatants were determined using ELISA kits. 
Following nano-WC–Co exposure, cell culture supernatants 
were collected after 6, 12, 24 and 48 h in 150 μL aliquots 
in a 96-well plate and preserved immediately at -80°C 
for later analysis. Once all supernatant samples had been 
collected, the 96-well plates were quickly thawed at room 
temperature and centrifuged briefly (500 rpm for 5 min) 
to pellet any cell debris or nano-WC–Co particles, which 
may interfere with the assay. The ELISA assays were then 
carried out according to the manufacturer’s instructions. 
Briefly, 100 μL supernatant or cytokine standard (prepared 
according to the instructions) was transferred to the appro-
priate well(s) of the 96-well ELISA plate and incubated at 
room temperature for 2.5 h with gentle shaking. Next, the 
solutions were discarded and each well was rinsed four times 
with prepared 1× wash buffer according to the instructions. 
Following the rinse step, 100 μL of biotinylated antibody 
was added to each well and incubated for 1 h with gentle 
shaking. Next, the solutions were discarded and the rinse step 
was repeated, followed by addition of 100 μL streptavidin 
solution to each well and incubation for 45 min with gentle 
shaking. Then, the solutions were discarded, the rinse step 
was repeated and 100 μL of tetramethylbenzidine (TMB) 
one-step substrate reagent was added to each well. Plates 
were incubated in the dark for an additional 30 min with 
gentle shaking, followed by the addition of 50 μL stop solu-
tion to each well. Plate absorbance was read immediately 
at 450 nm. Standard curves were prepared in duplicate for 
each ELISA plate. The concentration of cytokine(s) in each 
supernatant sample was then calculated based on the sample 
absorbance at 450 nm and the slope of the standard curve, 
according to the instructions.
Statistical analyses
All experiments were performed in triplicate, and data 
are presented as mean ± standard deviation. Statistical 
analysis was carried out by two-way analysis of variance 
(ANOVA) using GraphPad Prism Software (GraphPad 
Software, Inc., La Jolla, CA, USA). P-values ,0.05 were 
considered significant.
Results
Nano-WC–Co characterization
Nano-WC–Co particles were prepared and characterized as 
described earlier.49 Briefly, nano-WC–Co particles averaged 
98 nm in diameter in suspension determined by dynamic 
light scattering and transmission electron microscopy. 
Compositional analysis by energy-dispersive X-ray (EDX) 
determined that nano-WC–Co contained 72.13% tungsten, 
13.42% cobalt, 7.63% carbon and 6.81% oxygen.
CC viability
Macrophages (THP-1), lung epithelial cells (BEAS-2B) and a 
3:1 CC of BEAS-2B and THP-1 cells were exposed to nano-
WC–Co at concentrations of 1, 10, 100 and 1,000 μg/mL for 
durations of 2, 6, 12, 24 and 48 h. In macrophage monoculture 
(THP-1), nano-WC–Co exposure did not induce significant 
changes in cell viability (compared to control) at 1 μg/mL 
but did induce a significant reduction in cell viability at 
10 μg/mL after 48 h, at 100 μg/mL after 6, 12, 24 and 48 h 
and at 1,000 μg/mL after 2, 6, 12, 24 and 48 h of exposure 
(Figure 1). Consistent with our previous report,49 nano-
WC–Co exposure caused a significant reduction in cell 
viability in lung epithelial cells (BEAS-2B) at 1 μg/mL after 
24 and 48 h and at $10 μg/mL after 2, 6, 12, 24 and 48 h of 
exposure (Figure 1). The viability in THP-1 cells was signifi-
cantly higher compared to BEAS-2B monoculture at 1 μg/mL 
after 2, 6 and 48 h and at 10, 100 and 1,000 μg/mL after 2, 6, 
12, 24 and 48 h nano-WC–Co exposure (Figure 1).
In the CC of BEAS-2B and THP-1 cells, nano-WC–Co 
exposure did not lead to significant changes in cell viability 
at 1 μg/mL but caused a significant reduction in cell viability 
(compared to control) at 10 μg/mL after 24 and 48 h and at 
100 and 1,000 μg/mL after 2, 6, 12, 24 and 48 h of exposure 
(Figure 1). Compared to BEAS-2B monoculture, an increased 
cell viability was observed in the CC model at 1 μg/mL 
after 24 and 48 h, at 10 μg/mL after 2, 6, 12, 24 and 48 h, 
at 100 μg/mL after 2, 24 and 48 h and at 1,000 μg/mL after 
2 and 6 h of exposure (Figure 1).
Macrophage polarization
Macrophage polarization toward the M1 and M2 phenotypes 
was examined after exposure to LPS (M1 positive control), 
IL-4 (M2 positive control) and 0, 1, 10 or 100 μg/mL nano-
WC–Co for 1, 2 and 5 days. Cells staining positive for 
CD40-APC were considered M1-type macrophages and cells 
staining positive for CD206-FITC were considered M2-type 
macrophages. A summary of M1 and M2 flow cytometry stain-
ing is presented graphically in Figure 2. Representative dot 
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plots depicting M1/M2 macrophage staining after exposure 
to nano-WC–Co for 1, 2 and 5 days are shown in Figure 3 
(1 μg/mL), Figure 4 (10 μg/mL) and Figure 5 (100 μg/mL). 
Compared to the control group (0 μg/mL nano-WC–Co), for 
the staining control samples used to set the instrument gating 
parameters, a significant increase in CD40+ stained cells was 
observed following LPS exposure for 1, 2 and 5 days; IL-4 
exposure caused a significant increase in CD206+ cells after 
2- and 5-day exposure (Figure S2).
In general, CD40+ staining was dominant in all the sam-
ples at the exposure periods studied (Figure 2). Compared to 
the control group (0 μg/mL WC–Co), cells exposed to 1 and 
10 μg/mL nano-WC–Co had significantly higher CD40+ 
staining after 5 days of exposure. Exposure to 10 μg/mL 
nano-WC–Co also caused a significant increase in CD40+ 
cells after 1 day and cells exposed to 100 μg/mL demon-
strated significantly lower numbers of CD40+ cells after 
2 and 5 days of exposure (Figure 2A). Further, cells exposed 
to 1, 10 and 100 μg/mL nano-WC–Co had significantly 
less CD206+ cells after 5 days of exposure compared to the 
control group (0 μg/mL WC–Co; Figure 2B). With increasing 
nano-WC–Co exposure time from day 1 to day 2 and day 5, 
an increase in the ratio of M2/M1 was found; the ratio of 
M2/M1 was significantly higher after 5 days compared to 
1 day for 1, 10 and 100 μg/mL nano-WC–Co (Figure 2C).
Inflammatory cytokine secretion
The levels of inflammatory cytokines were quantified in 
the cell culture supernatant via ELISA after 6, 12, 24 and 
48 h of exposure to 0, 1, 10 or 100 μg/mL nano-WC–Co 
(Figure 6) and either LPS (M1 stimulus) or IL-4 (M2 stimu-
lus; Figures S3 and S4). Nano-WC–Co treatment caused 
varying effects on TNFα secretion (Figure 6A); 1 μg/mL 
nano-WC–Co caused a significant increase (P,0.05) in 
TNFα after 6 h of exposure, compared to control (0 μg/mL), 
but the levels were significantly lower after 12, 24 and 48 h 
of exposure. A decrease in TNFα, compared to control 
(0 μg/mL), was also observed at 10 μg/mL after 24 and 
48 h and at 100 μg/mL after 12, 24 and 48 h of exposure to 
nano-WC–Co (Figure 6A).
Figure 1 Cell viability after exposure to (A) 1 μg/ml, (B) 10 μg/ml, (C) 100 μg/ml and (D) 1,000 μg/mL nano-WC–Co particles in macrophages (THP-1), lung epithelial 
cells (BEAS-2B) and 3:1 CC (BEAS-2B:THP-1).
Notes: *P,0.05, #P,0.01 compared to control; ‡P,0.05 compared to Beas-2B monoculture.
Abbreviations: CC, coculture; WC–Co, tungsten carbide–cobalt; h, hours.
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In the IL-1β assay (Figure 6B), 1 μg/mL nano-WC–Co 
treatment caused a significant increase in IL-1β levels, 
compared to control (0 μg/mL), after 12 and 24 h of exposure. 
In the 10 μg/mL nano-WC–Co group, a significant increase in 
IL-1β was found at exposures of 12, 24 and 48 h. Compared 
to control (0 μg/mL), 100 μg/mL nano-WC–Co exposure 
led to a significant decrease in IL-1β after 6 and 12 h and 
a significant increase after 24 h followed by a significant 
decrease after 48 h of exposure (Figure 6B).
For IL-12 (Figure 6C), exposure to 1 μg/mL nano-
WC–Co caused a significant increase compared to control 
(0 μg/mL) after 12 h of exposure. Then, 10 μg/mL nano-
WC–Co caused a significant increase in IL-12 after 12 and 
48 h of exposure and 100 μg/mL nano-WC–Co also caused 
a significant increase in IL-12 (compared to control) after 6, 
12 and 48 h of exposure (Figure 6C).
Discussion
Due to the increased use of NPs in consumer and industrial 
applications,52 there is a critical need to clearly define the toxic 
and inflammatory effects of NPs which occur after exposure. 
We recently reported that commercially prepared nano-
WC–Co particles induced a time- and dose-dependent toxicity 
in human lung epithelial cells (BEAS-2B) and were capable 
of being internalized, inducing oxidative stress and stimulat-
ing apoptotic cell death in vitro.49 Since macrophages play a 
critical role in promoting natural pulmonary particle clearance 
mechanisms, an important aspect of the current study was to 
define the toxic effects of nano-WC–Co particle exposure on 
macrophages in both monoculture and CC settings. To test 
the effects of nano-WC–Co particle exposure on macrophage-
mediated inflammation and M1/M2 polarization, we selected 
monocyte-derived THP-1 cells as our macrophage model due 
to their prevalence in the literature and the ease with which 
THP-1 cells are differentiated toward a macrophage (M0) 
phenotype with PMA.13,14,51,53 In this study, a 3:1 CC ratio of 
BEAS-2B to THP-1 M0 was selected to represent the dynamic 
tissue environment within the lung during a particle inhalation 
scenario;54,55 the viability was compared between THP-1 and 
BEAS-2B monocultures and the 3:1 CC system.
Figure 2 Summary of macrophage flow cytometry staining as total percentage of (A) cD40+/M1, (B) cD206+/M2 and (C) M2/M1 ratio after exposure to nano-Wc–co 
particles for 1, 2 and 5 days.
Notes: *P,0.05 compared to 0 μg/ml (M0) control (A, B) and #P,0.01 compared to 1 day (C).
Abbreviation: Wc–co, tungsten carbide–cobalt.

0
0
UDWL
R
 'D\VRIH[SRVXUH 
 

J:&±&R J:&±&R J:&±&R&
   1DQR:&±&RFRQFHQWUDWLRQJP/
&'
$
3&







GD\ GD\V GD\V GD\ GD\V GD\V






&'
)
,7&


  1DQR:&±&RFRQFHQWUDWLRQJP/


 
$ %
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
76
.1
20
.1
80
.1
19
 o
n 
02
-J
un
-2
02
0
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
6201
Inflammatory effects of hard metal nanoparticles
Due to the inherent phagocytic nature of macrophages, 
we hypothesized that the presence of THP-1 M0 in the CC 
model would offer a “protective effect” against nano-WC–Co 
toxicity; therefore, increased viability would be observed in 
the CC system compared to BEAS-2B cells alone. In this case, 
the results of our cell viability study (Figure 1) are consistent 
with our hypothesis and we believe that macrophage engulf-
ment of nano-WC–Co isolated the particles and prevented 
direct contact with the BEAS-2B cells, effectively attenuating 
nano-WC–Co toxicity to the extent reported previously in 
BEAS-2B cells.49 In fact, the toxicity of nano-WC–Co was 
found to be cell dependent and significantly less toxicity 
was observed in macrophages compared to BEAS-2B cells 
(Figure 2). While the 1,000 μg/mL dose is very high, we 
believe that it is relevant because the resulting lifetime accu-
mulation of nano-WC–Co particles in the lung from occu-
pational settings could be substantial. This idea is supported 
by histological findings in patients with HMLD, where large 
deposits of WC–Co are often visible in lung specimens.56–59
Macrophage polarization following the exposure to other 
metal NPs has been reported,60 so we explored the effects 
of nano-WC–Co exposure on macrophage polarization 
toward the M1 or M2 phenotype using flow cytometry 
by staining for two well-known macrophage cell mem-
brane markers: CD40 as an M1 surface marker and 
CD206 (mannose receptor) as an M2 macrophage surface 
marker.12–14 Overall, high levels of CD40+/M1 staining 
were observed in nano-WC–Co-particle-exposed groups 
(Figure 2A) and in the LPS-stimulated M1 positive control 
group (Figure S2A). The prevalence of CD40+/M1 staining 
was much higher in nano-WC–Co-exposed groups than 
CD206+/M2 staining; while a slight increase in CD206+/M2 
staining was observed at 5 days compared to 1 and 
2 days after nano-WC–Co exposure; overall, the levels 
of CD206+/M2 macrophages were significantly lower than 
the control (0 μg/mL) group (Figure 2B). It seems that the 
ratio of M2/M1 increased with increasing exposure time 
(Figure 2C).
Figure 3 Representative flow cytometry dot plots depicting macrophage staining after exposure to 1 μg/ml nano-Wc–co particles for (A) 1 day, (B) 2 days, and 
(C) 5 days.
Notes: CD40-APC as surface marker of M1-type macrophages and CD206-FITC as surface marker of M2-type macrophages.
Abbreviations: FITC, fluorescein isothiocyanate; Neg, negative; WC–Co, tungsten carbide–cobalt.
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Therefore, at least in terms of surface marker expres-
sion, nano-WC–Co particles appear to induce strong CD40 
expression, typical of an M1 classically activated pheno-
type, rather than increased levels of CD206 expression 
associated with M2 alternatively activated macrophages. 
However, there are a few potential limitations that may 
have contributed to the lack of CD206+ macrophages in 
our cell populations. Upon stimulation with PMA, THP-1 
macrophages became extremely adherent to the culture dish 
and were difficult to detach for membrane surface staining; 
hence, it is possible that CD206 membrane receptors may 
have been damaged during the detachment process, causing 
low numbers of CD206+ cells overall. In addition, in our 
control (0 μg/mL) group, receiving PMA treatment only, 
a high level of CD40+/M1 staining was observed, which may 
indicate a predisposition toward the M1 surface markers in 
our control cells.
Next, we examined the secretion of pro-inflammatory cytok-
ines including TNFα, IL-1β and IL-12 over an exposure period 
ranging from 6 to 48 h to determine the effects of nano-WC–Co 
exposure on cytokine expression over time (Figure 6). Given 
the strong CD40+/M1-type inflammatory macrophage surface 
marker expression in our flow cyto metry assay, we expected to 
see complementary induction of pro-inflammatory cytokines 
in our ELISA assay. Typically, TNFα is secreted by activated 
macrophages and plays a primary role in the inflammatory 
immune response associated with infections due to bacterial or 
viral pathogens, such as promoting neutrophil chemotaxis and 
inducing acute phase proteins (C-reactive protein).61 A mixed 
TNFα response was observed in nano-WC-Co-treated mac-
rophages compared to the control group, with higher levels 
after 6 h of exposure to low concentration (1 μg/mL) but 
similar or lower levels of TNFα compared to control at 10 
and 100 μg/mL (Figure 6A).
Figure 4 Representative flow cytometry dot plots depicting macrophage staining after exposure to 10 μg/ml nano-Wc–co particles for (A) 1 day, (B) 2 days and 
(C) 5 days.
Notes: CD40-APC as surface marker of M1-type macrophages and CD206-FITC as surface marker of M2-type macrophages.
Abbreviations: FITC, fluorescein isothiocyanate; Neg, negative; WC–Co, tungsten carbide–cobalt.
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Figure 5 Representative flow cytometry dot plots depicting macrophage staining after exposure to 100 μg/ml nano-Wc–co particles for (A) 1 day, (B) 2 days and 
(C) 5 days.
Notes: CD40-APC as surface marker of M1-type macrophages and CD206-FITC as surface marker of M2-type macrophages.
Abbreviations: FITC, fluorescein isothiocyanate; Neg, negative; WC–Co, tungsten carbide–cobalt.
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IL-1β is a potent inflammatory cytokine that plays a 
critical role in the immune response to infection by promot-
ing adhesion factors on endothelial cells, which allows for 
migration of macrophages and neutrophils to the site of 
infection.62 IL-1β is known to enhance systemic inflamma-
tion and mediate autoimmune disorders, such as rheumatoid 
arthritis.62,63 In contrast to TNFα, significantly higher levels 
of IL-1β, compared to control, were observed in all three 
nano-WC–Co treatment groups after 24 h of exposure and 
for the 1 and 10 μg/mL groups after 12 h (Figure 6B). Since 
IL-1β is produced largely by activated macrophages, the 
induction of high levels of IL-1β secretion may indicate 
a pro-inflammatory response and increased activation in 
macrophages exposed to nano-WC–Co particles.
IL-12 is known to induce phagocytic activation of mac-
rophages, natural killer cells and cytotoxic T-lymphocytes 
as part of the innate immune response to bacterial, parasitic 
or intracellular infections.64–69 IL-12 also acts as an inducer 
of other cytokines, such as interferon-gamma (IFNγ). Like 
IL-1β, IL-12 may also contribute to chronic inflammation in 
rheumatoid arthritis, psoriasis and other immune disorders.64 
In our THP-1 macrophage model, nano-WC–Co exposure 
also stimulated IL-12 secretion, since significantly higher 
IL-12 levels were found in nano-WC–Co-treated cells, com-
pared to control, after 12 h of exposure (Figure 6C).
In addition, it is worth considering how the toxic effects 
of nano-WC–Co particles toward THP-1 macrophages 
(Figure 1) may have impacted the results of our inflammatory 
cytokine assay. In general, the 1 μg/mL nano-WC–Co dose 
was nontoxic up to 48 h in our viability assay, so higher 
observed levels of TNFα, IL-1β and IL-12 at this concen-
tration are likely to reflect increased inflammatory cytokine 
secretion overall in nano-WC–Co-exposed macrophage 
populations. In contrast, significant toxicity was observed 
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Figure 6 Secretion of pro-inflammatory cytokines such as (A) TNFα, (B) Il-1β and (C) IL-12 in cell culture supernatant as markers of inflammation following nano-WC–Co 
exposure.
Notes: *P,0.05, #P,0.01 compared to 0 μg/ml (M0) control.
Abbreviations: IL, interleukin; TNFα, tumor necrosis factor alpha; WC–Co, tungsten carbide–cobalt; h, hours.
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after 48 h of exposure to 10 μg/mL nano-WC–Co, so the 
lower levels of secreted inflammatory cytokines at this 
concentration seem consistent with increased nano-WC–Co 
toxicity at this time point. In addition, 100 μg/mL nano-
WC–Co was toxic toward THP-1 macrophages at 6 h and 
beyond, and thus the secretion of increased levels of IL-12 
(compared to control) at this concentration is especially 
significant, indicating that the remaining live macrophages 
(,80% compared to control) are stimulated to undergo a 
very strong IL-12-mediated inflammatory response. Overall, 
these results are consistent with our hypothesis and demon-
strate that nano-WC–Co particles are capable of inducing a 
pro-inflammatory response in macrophages marked by high 
levels of IL-1β and IL-12 secretion and high expression of 
CD40 M1 surface markers.
Conclusion
This study examined the toxicity of nano-WC–Co in a CC, 
for the first time, of macrophages and lung epithelial cells 
and explored the effects of nano-WC–Co exposure on M1/M2 
polarization and inflammatory cytokine secretion in THP-1 
macrophages. The presence of THP-1 cells in the CC model 
was found to reduce the toxicity of nano-WC–Co compared to 
a monoculture of BEAS-2B cells, which suggested a protective 
role of macrophages against nano-WC–Co particle toxicity. 
In macrophages, nano-WC–Co exposure induced increased 
secretion of IL-1β and IL-12, which are indicators of a pro-
inflammatory response. The M1/M2 polarization assay indi-
cated a strong M1 phenotype (CD40+) in nano-WC–Co-treated 
macrophages after 1, 2 and 5 days of exposure. Overall, the 
outcomes of our cytokine ELISA and flow cytometry assay 
indicated that exposure to nano-WC–Co particles in vitro 
stimulates a pro-inflammatory cytokine response and polariza-
tion toward the M1 phenotype in macrophages.
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